RARA CRAFT DATABASE for FDA Medical Devices
510(k)K172333

FDA DEVICE FACTS

Sysmex CS-5100

Siemens Healthcare Diagnostics Products GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 31, 2017PRODUCT CODEJPA

Indications for use

The Sysmex® Automated Blood Coagulation Analyzer CS-5100 is a fully automated blood coagulation analyzer intended for in vitro diagnostic use using plasma collected from venous blood samples in 3.2% sodium citrate tubes to analyze clotting, chromogenic and immunoassay methods in the clinical laboratory. For determination of:

• Prothrombin Time (PT) seconds and PT INR with Dade® Innovin®

• Activated Partial Thromboplastin Time (APTT) with Dade® Actin® FSL

• Fibrinogen (Fbg) with Dade® Thrombin Reagent

• Coagulation Factor V with Dade® Innovin®

• Coagulation Factor VII with Dade® Innovin®

• Coagulation Factor VIII with Dade® Actin® FSL

• Coagulation Factor IX with Dade® Actin® FSL

• Lupus Anticoagulant with LA1 Screening and LA2 Confirmation Reagent

• Factor V Leiden with Factor V Leiden Assay

• Protein C with Protein C Reagent

• Antithrombin (AT) with INNOVANCE® Antithrombin

• Protein C with Berichrom® Protein C

• D-dimer with INNOVANCE® D-Dimer The performance of this device has not been established in neonate and pediatric patient populations.

Intended Use for Factor V Leiden Assay: The Siemens Healthcare Diagnostics Factor V Leiden Assay is a simple functional clotting test system intended for screening of resistance to Activated Protein C (APC) in plasma from individuals with Factor V (Leiden) defect. For in vitro diagnostic use.

Intended Use for Coagulation Factor VIII Deficient Plasma: In vitro diagnostic reagents for the determination of the activity of coagulation factors VIII, IX, XI and XII in human plasma by coagulation methods.

Intended Use for Coagulation Factor IX Deficient Plasma: In vitro diagnostic reagents for the determination of the activity of coagulation factor VIII, IX, XI and XII in human plasma by coagulation methods.

Intended Use for LA1 Screening and LA2 Confirmation Reagents: LA1 Screening Reagent and LA2 Confirmation Reagent are simplified DRVVT reagents for detection of Lupus Anticoagulants (LA) in one-stage clotting tests. LA1 Screening Reagent: Simplified DRVV reagent to screen for the presence of Lupus Anticoagulants. LA2 Confirmation Reagent: Phospholipid-rich DRVV reagent for the specific correction of Lupus Anticoagulants.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026